Moderna Inc. was hit with a new lawsuit alleging the vaccine maker’s Spikevax Covid-19 shots infringe 10 CureVac SE patents ...
By Blake Brittain April 24 (Reuters) - German biotech company CureVac sued Moderna in Delaware federal court on Friday, ...
This week, the European Commission authorized Moderna to market the vaccine, mRNA-1083 or mCOMBRIAX, making it the world’s ...
Morning Overview on MSN
Europe becomes first to authorize Moderna’s combined flu-COVID mRNA shot
Starting this autumn, adults aged 50 and older across the European Union may be able to roll up their sleeve just once and ...
Sanofi’s protein-based vaccine Nuvaxovid has conquered Moderna’s next-generation messenger RNA shot mNexspike in a ...
COMBRIAX is the world's first flu plus COVID combination vaccine to receive marketing authorization and Moderna's ...
Moderna initiated a large clinical trial of an mRNA vaccine for bird flu, despite delays due to HHS funding cuts.
Moderna wins EU approval for its COVID-19-flu combo shot mCombriax, backed by strong phase III data showing superior immune ...
Having already received two doses of the Moderna COVID-19 vaccine, she shrugged it off as a cold. To be safe, though, she searched COVID-19 symptoms on Google — cough, fever, runny nose, trouble ...
March 4 (Reuters) - Moderna shares rose 9% on Wednesday after it settled a long-running legal battle over the technology that made its COVID-19 vaccine possible, removing an overhang and allowing ...
The US drugmaker said it was informed by the Data Safety Monitoring Board that its vaccine had met statistical criteria ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results